nodes	percent_of_prediction	percent_of_DWPC	metapath
Enprofylline—ADORA2B—decidua—ovarian cancer	0.0697	0.0779	CbGeAlD
Enprofylline—PDE4A—decidua—ovarian cancer	0.0621	0.0694	CbGeAlD
Enprofylline—ADORA2A—gonad—ovarian cancer	0.051	0.0571	CbGeAlD
Enprofylline—ADORA2B—vagina—ovarian cancer	0.0495	0.0554	CbGeAlD
Enprofylline—Theophylline—CYP1B1—ovarian cancer	0.0457	1	CrCbGaD
Enprofylline—ADORA2A—female reproductive system—ovarian cancer	0.0456	0.051	CbGeAlD
Enprofylline—PDE4A—female gonad—ovarian cancer	0.0444	0.0497	CbGeAlD
Enprofylline—ADORA2B—testis—ovarian cancer	0.0442	0.0494	CbGeAlD
Enprofylline—PDE4A—testis—ovarian cancer	0.0394	0.0441	CbGeAlD
Enprofylline—ADORA1—female reproductive system—ovarian cancer	0.0394	0.044	CbGeAlD
Enprofylline—PDE4B—uterine cervix—ovarian cancer	0.0389	0.0434	CbGeAlD
Enprofylline—PDE4B—decidua—ovarian cancer	0.037	0.0414	CbGeAlD
Enprofylline—ADORA2A—testis—ovarian cancer	0.0368	0.0411	CbGeAlD
Enprofylline—ADORA1—vagina—ovarian cancer	0.0356	0.0398	CbGeAlD
Enprofylline—PDE4B—endometrium—ovarian cancer	0.0351	0.0393	CbGeAlD
Enprofylline—PDE4B—gonad—ovarian cancer	0.0326	0.0364	CbGeAlD
Enprofylline—ADORA1—testis—ovarian cancer	0.0318	0.0355	CbGeAlD
Enprofylline—PDE4B—female reproductive system—ovarian cancer	0.0291	0.0325	CbGeAlD
Enprofylline—PDE4A—lymph node—ovarian cancer	0.0286	0.0319	CbGeAlD
Enprofylline—PDE4B—bone marrow—ovarian cancer	0.0275	0.0307	CbGeAlD
Enprofylline—PDE4B—female gonad—ovarian cancer	0.0265	0.0296	CbGeAlD
Enprofylline—PDE4B—vagina—ovarian cancer	0.0263	0.0294	CbGeAlD
Enprofylline—PDE4B—testis—ovarian cancer	0.0235	0.0263	CbGeAlD
Enprofylline—ADORA1—lymph node—ovarian cancer	0.023	0.0257	CbGeAlD
Enprofylline—PDE4B—lymph node—ovarian cancer	0.017	0.019	CbGeAlD
Enprofylline—ADORA2B—Signaling by GPCR—PIK3CB—ovarian cancer	7.86e-05	0.00131	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—PIK3CB—ovarian cancer	7.86e-05	0.00131	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—PPP2R1A—ovarian cancer	7.7e-05	0.00129	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—PIK3CD—ovarian cancer	7.67e-05	0.00128	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—IL6—ovarian cancer	7.66e-05	0.00128	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—PPP2R1A—ovarian cancer	7.61e-05	0.00127	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—PIK3CD—ovarian cancer	7.58e-05	0.00127	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—CXCL8—ovarian cancer	7.55e-05	0.00126	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—CXCL8—ovarian cancer	7.55e-05	0.00126	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—PIK3CG—ovarian cancer	7.42e-05	0.00124	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—PIK3CB—ovarian cancer	7.36e-05	0.00123	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PARP1—ovarian cancer	7.33e-05	0.00122	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—PIK3CB—ovarian cancer	7.27e-05	0.00121	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—IL2—ovarian cancer	7.22e-05	0.00121	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—IL2—ovarian cancer	7.22e-05	0.00121	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—TERT—ovarian cancer	7.19e-05	0.0012	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—PIK3CB—ovarian cancer	7.14e-05	0.00119	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—CXCL8—ovarian cancer	7.07e-05	0.00118	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by NGF—AKT1—ovarian cancer	7.07e-05	0.00118	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—IL6ST—ovarian cancer	7.01e-05	0.00117	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—CXCL8—ovarian cancer	6.99e-05	0.00117	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—CXCL8—ovarian cancer	6.86e-05	0.00115	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—IL2—ovarian cancer	6.76e-05	0.00113	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—PIK3CG—ovarian cancer	6.73e-05	0.00113	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—PIK3CB—ovarian cancer	6.68e-05	0.00112	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—IL2—ovarian cancer	6.68e-05	0.00112	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CAV1—ovarian cancer	6.65e-05	0.00111	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—PIK3CB—ovarian cancer	6.6e-05	0.0011	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—IL2—ovarian cancer	6.55e-05	0.0011	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—TERT—ovarian cancer	6.53e-05	0.00109	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—PIK3CD—ovarian cancer	6.52e-05	0.00109	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—CXCL8—ovarian cancer	6.42e-05	0.00107	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—ESR1—ovarian cancer	6.41e-05	0.00107	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—CXCL8—ovarian cancer	6.35e-05	0.00106	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IL6ST—ovarian cancer	6.31e-05	0.00105	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—IL2—ovarian cancer	6.14e-05	0.00103	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—TERT—ovarian cancer	6.12e-05	0.00102	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—IL2—ovarian cancer	6.06e-05	0.00101	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—PIK3CG—ovarian cancer	6.06e-05	0.00101	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—APC—ovarian cancer	6.06e-05	0.00101	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—NRAS—ovarian cancer	6.06e-05	0.00101	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—TERT—ovarian cancer	6.04e-05	0.00101	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CAV1—ovarian cancer	6.04e-05	0.00101	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PPP2R1A—ovarian cancer	5.94e-05	0.000993	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—PIK3CD—ovarian cancer	5.92e-05	0.000989	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—ESR1—ovarian cancer	5.82e-05	0.000972	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—MAPK3—ovarian cancer	5.8e-05	0.00097	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IL6ST—ovarian cancer	5.73e-05	0.000957	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—PIK3CB—ovarian cancer	5.68e-05	0.000949	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CAV1—ovarian cancer	5.66e-05	0.000945	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CAV1—ovarian cancer	5.59e-05	0.000934	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—MAPK1—ovarian cancer	5.52e-05	0.000922	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—EGFR—ovarian cancer	5.52e-05	0.000922	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—APC—ovarian cancer	5.5e-05	0.000919	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—PIK3CG—ovarian cancer	5.5e-05	0.000919	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—NRAS—ovarian cancer	5.5e-05	0.000919	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—CXCL8—ovarian cancer	5.46e-05	0.000912	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—ESR1—ovarian cancer	5.45e-05	0.000911	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—ESR1—ovarian cancer	5.39e-05	0.0009	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IL6ST—ovarian cancer	5.36e-05	0.000896	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—PIK3CD—ovarian cancer	5.33e-05	0.00089	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IL6ST—ovarian cancer	5.3e-05	0.000885	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—PIK3CA—ovarian cancer	5.28e-05	0.000881	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—MAPK3—ovarian cancer	5.27e-05	0.00088	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—IL2—ovarian cancer	5.22e-05	0.000872	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—KRAS—ovarian cancer	5.22e-05	0.000871	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—PIK3CB—ovarian cancer	5.16e-05	0.000862	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—PIK3CG—ovarian cancer	5.15e-05	0.000861	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—APC—ovarian cancer	5.15e-05	0.000861	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—NRAS—ovarian cancer	5.15e-05	0.000861	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—PIK3CG—ovarian cancer	5.09e-05	0.000851	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—APC—ovarian cancer	5.09e-05	0.000851	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—NRAS—ovarian cancer	5.09e-05	0.000851	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—MAPK1—ovarian cancer	5.01e-05	0.000838	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—EGFR—ovarian cancer	5.01e-05	0.000837	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—CXCL8—ovarian cancer	4.96e-05	0.000828	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—MAPK3—ovarian cancer	4.93e-05	0.000824	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—MAPK3—ovarian cancer	4.88e-05	0.000815	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—PIK3CD—ovarian cancer	4.84e-05	0.000808	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—PIK3CA—ovarian cancer	4.79e-05	0.0008	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—PIK3CA—ovarian cancer	4.79e-05	0.0008	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—IL2—ovarian cancer	4.74e-05	0.000792	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—KRAS—ovarian cancer	4.74e-05	0.000791	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—TERT—ovarian cancer	4.72e-05	0.000789	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—ERBB2—ovarian cancer	4.7e-05	0.000786	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—MAPK1—ovarian cancer	4.7e-05	0.000784	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—EGFR—ovarian cancer	4.69e-05	0.000784	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—MTOR—ovarian cancer	4.64e-05	0.000776	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—PIK3CB—ovarian cancer	4.64e-05	0.000776	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—MAPK1—ovarian cancer	4.64e-05	0.000775	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—EGFR—ovarian cancer	4.64e-05	0.000775	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—PIK3CD—ovarian cancer	4.53e-05	0.000757	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—PIK3CA—ovarian cancer	4.49e-05	0.00075	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—PIK3CD—ovarian cancer	4.48e-05	0.000748	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CXCL8—ovarian cancer	4.46e-05	0.000745	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—KRAS—ovarian cancer	4.43e-05	0.000741	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—PIK3CA—ovarian cancer	4.43e-05	0.000741	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—HRAS—ovarian cancer	4.43e-05	0.000741	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—KRAS—ovarian cancer	4.38e-05	0.000732	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CAV1—ovarian cancer	4.37e-05	0.00073	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CDKN1B—ovarian cancer	4.36e-05	0.000728	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—PIK3CA—ovarian cancer	4.35e-05	0.000727	CbGpPWpGaD
Enprofylline—ADORA2B—GPCR downstream signaling—AKT1—ovarian cancer	4.31e-05	0.00072	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—ERBB2—ovarian cancer	4.27e-05	0.000714	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CASP3—ovarian cancer	4.27e-05	0.000713	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IL2—ovarian cancer	4.26e-05	0.000712	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—IL6—ovarian cancer	4.24e-05	0.000709	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—MTOR—ovarian cancer	4.22e-05	0.000704	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—PIK3CB—ovarian cancer	4.22e-05	0.000704	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—ESR1—ovarian cancer	4.21e-05	0.000703	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CCND1—ovarian cancer	4.16e-05	0.000694	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IL6ST—ovarian cancer	4.14e-05	0.000692	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—CTNNB1—ovarian cancer	4.12e-05	0.000688	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—PIK3CA—ovarian cancer	4.07e-05	0.000681	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CXCL8—ovarian cancer	4.05e-05	0.000677	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—MMP9—ovarian cancer	4.04e-05	0.000674	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—PIK3CA—ovarian cancer	4.03e-05	0.000673	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—HRAS—ovarian cancer	4.03e-05	0.000672	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—PTEN—ovarian cancer	4.01e-05	0.00067	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—ERBB2—ovarian cancer	4e-05	0.000668	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—APC—ovarian cancer	3.98e-05	0.000665	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PIK3CG—ovarian cancer	3.98e-05	0.000665	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—NRAS—ovarian cancer	3.98e-05	0.000665	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CDKN1B—ovarian cancer	3.96e-05	0.000661	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—ERBB2—ovarian cancer	3.95e-05	0.00066	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—PIK3CB—ovarian cancer	3.95e-05	0.00066	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—MTOR—ovarian cancer	3.95e-05	0.00066	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling by GPCR—AKT1—ovarian cancer	3.91e-05	0.000654	CbGpPWpGaD
Enprofylline—PDE4A—GPCR downstream signaling—AKT1—ovarian cancer	3.91e-05	0.000654	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—MTOR—ovarian cancer	3.9e-05	0.000652	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—PIK3CB—ovarian cancer	3.9e-05	0.000652	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CASP3—ovarian cancer	3.88e-05	0.000648	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IL2—ovarian cancer	3.87e-05	0.000647	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—IL6—ovarian cancer	3.85e-05	0.000644	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—MAPK3—ovarian cancer	3.81e-05	0.000636	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CXCL8—ovarian cancer	3.79e-05	0.000634	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CCND1—ovarian cancer	3.77e-05	0.000631	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—HRAS—ovarian cancer	3.77e-05	0.00063	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CXCL8—ovarian cancer	3.75e-05	0.000626	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—CTNNB1—ovarian cancer	3.74e-05	0.000624	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—HRAS—ovarian cancer	3.72e-05	0.000622	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CDKN1B—ovarian cancer	3.7e-05	0.000619	CbGpPWpGaD
Enprofylline—ADORA1—GPCR downstream signaling—AKT1—ovarian cancer	3.66e-05	0.000612	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—MMP9—ovarian cancer	3.66e-05	0.000612	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CDKN1B—ovarian cancer	3.66e-05	0.000612	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—PTEN—ovarian cancer	3.64e-05	0.000609	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CASP3—ovarian cancer	3.63e-05	0.000607	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IL2—ovarian cancer	3.63e-05	0.000606	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—MAPK1—ovarian cancer	3.62e-05	0.000606	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—EGFR—ovarian cancer	3.62e-05	0.000605	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—VEGFA—ovarian cancer	3.62e-05	0.000605	CbGpPWpGaD
Enprofylline—PDE4B—GPCR downstream signaling—AKT1—ovarian cancer	3.62e-05	0.000605	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—IL6—ovarian cancer	3.61e-05	0.000603	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—STAT3—ovarian cancer	3.59e-05	0.000599	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CASP3—ovarian cancer	3.59e-05	0.000599	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IL2—ovarian cancer	3.58e-05	0.000599	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—NRAS—ovarian cancer	3.58e-05	0.000598	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—IL6—ovarian cancer	3.56e-05	0.000596	CbGpPWpGaD
Enprofylline—PDE4A—Signaling by GPCR—AKT1—ovarian cancer	3.55e-05	0.000594	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CCND1—ovarian cancer	3.53e-05	0.00059	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—CTNNB1—ovarian cancer	3.5e-05	0.000585	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PIK3CD—ovarian cancer	3.5e-05	0.000584	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CCND1—ovarian cancer	3.49e-05	0.000583	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—PIK3CA—ovarian cancer	3.46e-05	0.000579	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—CTNNB1—ovarian cancer	3.46e-05	0.000578	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—MMP9—ovarian cancer	3.43e-05	0.000573	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—MAPK3—ovarian cancer	3.43e-05	0.000573	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—KRAS—ovarian cancer	3.42e-05	0.000572	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—PTEN—ovarian cancer	3.41e-05	0.00057	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—MMP9—ovarian cancer	3.39e-05	0.000566	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—PTEN—ovarian cancer	3.37e-05	0.000563	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—MYC—ovarian cancer	3.33e-05	0.000557	CbGpPWpGaD
Enprofylline—ADORA1—Signaling by GPCR—AKT1—ovarian cancer	3.33e-05	0.000556	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—VEGFA—ovarian cancer	3.29e-05	0.00055	CbGpPWpGaD
Enprofylline—PDE4B—Signaling by GPCR—AKT1—ovarian cancer	3.29e-05	0.000549	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—MAPK1—ovarian cancer	3.26e-05	0.000545	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—EGFR—ovarian cancer	3.26e-05	0.000545	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—STAT3—ovarian cancer	3.26e-05	0.000544	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—NRAS—ovarian cancer	3.25e-05	0.000543	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—PIK3CA—ovarian cancer	3.15e-05	0.000526	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—MAPK3—ovarian cancer	3.11e-05	0.00052	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—ERBB2—ovarian cancer	3.09e-05	0.000516	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—VEGFA—ovarian cancer	3.08e-05	0.000515	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—KRAS—ovarian cancer	3.08e-05	0.000515	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—STAT3—ovarian cancer	3.05e-05	0.00051	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PIK3CB—ovarian cancer	3.05e-05	0.000509	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—MTOR—ovarian cancer	3.05e-05	0.000509	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—VEGFA—ovarian cancer	3.04e-05	0.000509	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—NRAS—ovarian cancer	3.04e-05	0.000508	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—MYC—ovarian cancer	3.03e-05	0.000506	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—STAT3—ovarian cancer	3.01e-05	0.000504	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—NRAS—ovarian cancer	3.01e-05	0.000502	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—MAPK1—ovarian cancer	2.96e-05	0.000495	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—EGFR—ovarian cancer	2.96e-05	0.000495	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CXCL8—ovarian cancer	2.93e-05	0.000489	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—MAPK3—ovarian cancer	2.91e-05	0.000487	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—HRAS—ovarian cancer	2.91e-05	0.000486	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—MAPK3—ovarian cancer	2.88e-05	0.000481	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CDKN1B—ovarian cancer	2.86e-05	0.000478	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—MYC—ovarian cancer	2.84e-05	0.000474	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—PIK3CA—ovarian cancer	2.83e-05	0.000473	CbGpPWpGaD
Enprofylline—ADORA2A—GPCR downstream signaling—AKT1—ovarian cancer	2.83e-05	0.000473	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CASP3—ovarian cancer	2.8e-05	0.000468	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—MYC—ovarian cancer	2.8e-05	0.000468	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IL2—ovarian cancer	2.8e-05	0.000468	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—KRAS—ovarian cancer	2.8e-05	0.000467	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—IL6—ovarian cancer	2.79e-05	0.000465	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—MAPK1—ovarian cancer	2.77e-05	0.000463	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—EGFR—ovarian cancer	2.77e-05	0.000463	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—MAPK1—ovarian cancer	2.74e-05	0.000458	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—EGFR—ovarian cancer	2.74e-05	0.000458	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—TP53—ovarian cancer	2.74e-05	0.000457	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CCND1—ovarian cancer	2.73e-05	0.000456	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—CTNNB1—ovarian cancer	2.7e-05	0.000451	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—MMP9—ovarian cancer	2.65e-05	0.000443	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PTEN—ovarian cancer	2.63e-05	0.00044	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—KRAS—ovarian cancer	2.62e-05	0.000438	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—HRAS—ovarian cancer	2.62e-05	0.000437	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—KRAS—ovarian cancer	2.59e-05	0.000432	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—PIK3CA—ovarian cancer	2.57e-05	0.000429	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling by GPCR—AKT1—ovarian cancer	2.57e-05	0.000429	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—IL6—ovarian cancer	2.51e-05	0.000419	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—TP53—ovarian cancer	2.49e-05	0.000415	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—PIK3CA—ovarian cancer	2.41e-05	0.000402	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—VEGFA—ovarian cancer	2.38e-05	0.000397	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—PIK3CA—ovarian cancer	2.38e-05	0.000397	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—HRAS—ovarian cancer	2.38e-05	0.000397	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—STAT3—ovarian cancer	2.36e-05	0.000394	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—NRAS—ovarian cancer	2.35e-05	0.000393	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—TP53—ovarian cancer	2.33e-05	0.000389	CbGpPWpGaD
Enprofylline—ADORA2B—Signaling Pathways—AKT1—ovarian cancer	2.31e-05	0.000386	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—TP53—ovarian cancer	2.3e-05	0.000384	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—IL6—ovarian cancer	2.28e-05	0.00038	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—MAPK3—ovarian cancer	2.25e-05	0.000376	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—HRAS—ovarian cancer	2.23e-05	0.000372	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—HRAS—ovarian cancer	2.2e-05	0.000368	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—MYC—ovarian cancer	2.19e-05	0.000366	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—MAPK1—ovarian cancer	2.14e-05	0.000358	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—EGFR—ovarian cancer	2.14e-05	0.000358	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—IL6—ovarian cancer	2.13e-05	0.000356	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—IL6—ovarian cancer	2.11e-05	0.000352	CbGpPWpGaD
Enprofylline—PDE4A—Signaling Pathways—AKT1—ovarian cancer	2.1e-05	0.000351	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—KRAS—ovarian cancer	2.02e-05	0.000338	CbGpPWpGaD
Enprofylline—ADORA1—Signaling Pathways—AKT1—ovarian cancer	1.97e-05	0.000328	CbGpPWpGaD
Enprofylline—PDE4B—Signaling Pathways—AKT1—ovarian cancer	1.94e-05	0.000325	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—PIK3CA—ovarian cancer	1.86e-05	0.00031	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—TP53—ovarian cancer	1.8e-05	0.0003	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—HRAS—ovarian cancer	1.72e-05	0.000287	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—IL6—ovarian cancer	1.65e-05	0.000275	CbGpPWpGaD
Enprofylline—ADORA2A—Signaling Pathways—AKT1—ovarian cancer	1.52e-05	0.000254	CbGpPWpGaD
